Pond GR et al. |
Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer. |
2012 |
Clin Genitourin Cancer |
pmid:23000202
|
Sonpavde G et al. |
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer. |
2012 |
Ann. Oncol. |
pmid:22112969
|
Pond GR et al. |
Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. |
2012 |
Eur. Urol. |
pmid:21715086
|
Imai A et al. |
Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects. |
2012 |
Cancer Res. |
pmid:22158856
|
Yang X et al. |
Identification and proteomic analysis of a novel gossypol-degrading fungal strain. |
2012 |
J. Sci. Food Agric. |
pmid:22002592
|
Mellon JE et al. |
Inhibitory effects of gossypol, gossypolone, and apogossypolone on a collection of economically important filamentous fungi. |
2012 |
J. Agric. Food Chem. |
pmid:22324794
|
Ionov M et al. |
Stability and antioxidant activity of gossypol derivative immobilized on N-polyvinylpyrrolidone. |
2012 |
Int. J. Biol. Macromol. |
pmid:22910577
|
Hedvat M et al. |
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. |
2012 |
Anticancer Agents Med Chem |
pmid:22931411
|
Varadarajan S et al. |
A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum. |
2012 |
Cell Death Differ. |
pmid:22955944
|
Wang AP et al. |
Effects of different sources and levels of dietary gossypol on gossypol residues in plasma and milk of lactating cows. |
2012 |
J. Dairy Sci. |
pmid:22916918
|
Schuler MA |
Insect P450s: mounted for battle in their war against toxins. |
2012 |
Mol. Ecol. |
pmid:22924794
|
Yang J et al. |
Synthesis and antiviral activities of novel gossypol derivatives. |
2012 |
Bioorg. Med. Chem. Lett. |
pmid:22226654
|
Jiang J et al. |
Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling. |
2012 |
Clin. Exp. Metastasis |
pmid:22167622
|
Wong FY et al. |
Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression. |
2012 |
PLoS ONE |
pmid:23226540
|
Thakur A et al. |
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells. |
2012 |
PLoS ONE |
pmid:23185240
|
Shen Y and Ye D |
Re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9. |
2012 |
Eur. Urol. |
pmid:21824719
|
Xin J et al. |
ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells. |
2013 |
Biomed. Pharmacother. |
pmid:23201009
|
Song T et al. |
3-Thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1) derivatives as pan-Bcl-2-inhibitors of Bcl-2, Bcl-xL and Mcl-1. |
2013 |
Bioorg. Med. Chem. |
pmid:23206987
|
Cheng P et al. |
The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells. |
2013 |
Cell Death Dis |
pmid:23392177
|
Ni Z et al. |
Natural Bcl-2 inhibitor (-)- gossypol induces protective autophagy via reactive oxygen species-high mobility group box 1 pathway in Burkitt lymphoma. |
2013 |
Leuk. Lymphoma |
pmid:23398207
|